629 filings
Page 7 of 32
NT 10-K
uf8611egqyr7
16 Mar 17
Notice of late annual filing
12:00am
424B3
tj5uz
6 Mar 17
Prospectus supplement
12:00am
8-K
2joudmglcfww
6 Mar 17
Provectus Biopharmaceuticals, Inc. Announces Extension of
12:00am
8-K
6klfmomo
24 Feb 17
Regulation FD Disclosure
12:00am
8-K
1rmr82q
23 Feb 17
Provectus Biopharmaceuticals Appoints Bruce Horowitz and Dominic Rodrigues As Special Advisers to the Board of Directors
12:00am
424B3
3wlmfrbscpa k48
21 Feb 17
Prospectus supplement
12:00am
8-K
87y1mh uu1pblnmjcx
21 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
7iiqxt 6pqlni6yzay
14 Feb 17
Other Events
12:00am
8-K
8go4hhb1 fwvo6ro8
13 Feb 17
Provectus Biopharmaceuticals, Inc. Announces Extension of
12:00am
424B3
oasq ngdoc1cofihi6t
9 Feb 17
Prospectus supplement
12:00am
8-K
vudxv3brf45c64u
9 Feb 17
Regulation FD Disclosure
12:00am
8-K
59cj06dzxopn nehb93
3 Feb 17
Entry into a Material Definitive Agreement
12:00am
424B4
jj8w4u2l9d8wr17nbtmr
31 Jan 17
Prospectus supplement with pricing info
12:00am
8-K
njkokx
31 Jan 17
Provectus Biopharmaceuticals, Inc. Announces Commencement of
12:00am
DEFA14A
hns8vsv 07rlrw
27 Jan 17
Additional proxy soliciting materials
12:00am
CORRESP
yk3l5l1d xjwej
27 Jan 17
Correspondence with SEC
12:00am
EFFECT
30h0weg
27 Jan 17
Notice of effectiveness
12:00am
CORRESP
gz1xuiu7
25 Jan 17
Correspondence with SEC
12:00am